These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 6793630)
1. Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition. Dejana E; Cerletti C; de Castellarnau C; Livio M; Galletti F; Latini R; de Gaetano G J Clin Invest; 1981 Oct; 68(4):1108-12. PubMed ID: 6793630 [TBL] [Abstract][Full Text] [Related]
2. Interference by sulfinpyrazone and salicylate of aspirin inhibition of platelet cyclooxygenase activity. Ali M; McDonald JW Prostaglandins Med; 1979 Dec; 3(6):327-32. PubMed ID: 121613 [TBL] [Abstract][Full Text] [Related]
3. Salicylamide reverses the aspirin-antagonistic effect of salicylic acid on rat platelet cyclooxygenase. Rizk M; Abdel-Rahman MS Prostaglandins Leukot Essent Fatty Acids; 1994 Nov; 51(5):363-7. PubMed ID: 7846108 [TBL] [Abstract][Full Text] [Related]
4. Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction. de Gaetano G; Cerletti C; Dejana E; Latini R Circulation; 1985 Dec; 72(6):1185-93. PubMed ID: 2998640 [TBL] [Abstract][Full Text] [Related]
5. Effect of aspirin and salicylate on platelet-vessel wall interactions in rabbits. Buchanan MR; Hirsh J Arteriosclerosis; 1984; 4(4):403-6. PubMed ID: 6380468 [TBL] [Abstract][Full Text] [Related]
6. Low-dose aspirin inhibits platelet and venous cyclo-oxygenase in man. Preston FE; Greaves M; Jackson CA; Stoddard CJ Thromb Res; 1982 Aug; 27(4):477-84. PubMed ID: 6815823 [TBL] [Abstract][Full Text] [Related]
7. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin. Clarke RJ; Mayo G; Price P; FitzGerald GA N Engl J Med; 1991 Oct; 325(16):1137-41. PubMed ID: 1891022 [TBL] [Abstract][Full Text] [Related]
8. Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man. Rosenkranz B; Fischer C; Meese CO; Frölich JC Br J Clin Pharmacol; 1986 Mar; 21(3):309-17. PubMed ID: 3083851 [TBL] [Abstract][Full Text] [Related]
9. Structural requirements for preventing the aspirin- and the arachidonate-induced inactivation of platelet cyclo-oxygenase: additional evidence for distinct enzymatic sites. Rotilio D; Joseph D; Hatmi M; Vargaftig BB Eur J Pharmacol; 1984 Jan; 97(3-4):197-208. PubMed ID: 6423393 [TBL] [Abstract][Full Text] [Related]
10. Differential salicylate-aspirin interaction on vascular prostacyclin and platelet thromboxane synthesis in patients undergoing saphenectomy. Dejana E; Costantini V; De Amicis G; Cerletti C; Lorenzi G; de Gaetano G Proc Soc Exp Biol Med; 1985 Dec; 180(3):533-7. PubMed ID: 3841210 [TBL] [Abstract][Full Text] [Related]
11. Effect of acetaminophen and salicylate on aspirin-induced inhibition of human platelet cyclo-oxygenase. Rao GH; Reddy KR; White JG Prostaglandins Leukot Med; 1982 Jul; 9(1):109-15. PubMed ID: 6813873 [TBL] [Abstract][Full Text] [Related]
12. Salicylate fails to prevent the inhibitory effect of 5,8,11,14-eicosatetraynoic acid on human platelet cyclo-oxygenase and lipoxygenase activities. Cerletti C; Livio M; Doni MG; De Gaetano G Biochim Biophys Acta; 1983 Aug; 759(1-2):125-7. PubMed ID: 6411131 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid. Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity. Higgs GA; Salmon JA; Henderson B; Vane JR Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1417-20. PubMed ID: 3103135 [TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effects of aspirin and sodium salicylate. Amann R; Peskar BA Eur J Pharmacol; 2002 Jun; 447(1):1-9. PubMed ID: 12106797 [TBL] [Abstract][Full Text] [Related]
16. The role of prostaglandins in platelet function. Burch JW; Majerus PW Semin Hematol; 1979 Jul; 16(3):196-207. PubMed ID: 113883 [No Abstract] [Full Text] [Related]
17. Slow intravenous administration of low dose aspirin inhibits both vascular and platelet cyclooxygenase activity: an experimental study in the rat. Gambino MC; Cerletti C; Marchi S; Garattini S; de Gaetano G Proc Soc Exp Biol Med; 1986 Jul; 182(3):287-90. PubMed ID: 3086889 [TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526 [TBL] [Abstract][Full Text] [Related]
19. Platelet adhesivity to subendothelium is influenced by polymorphonuclear leukocytes: studies with aspirin and salicylate. Hernández R; Alemany M; Bozzo J; Buchanan MR; Ordinas A; Bastida E Haemostasis; 1993; 23(1):1-7. PubMed ID: 8477903 [TBL] [Abstract][Full Text] [Related]
20. Thrombogenic effect of high-dose aspirin in rabbits. Relationship to inhibition of vessel wall synthesis of prostaglandin I2-like activity. Kelton JG; Hirsh J; Carter CJ; Buchanan MR J Clin Invest; 1978 Oct; 62(4):892-5. PubMed ID: 359598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]